NCT07481305From ClinicalTrials.govRecruiting

Lifestyle Change Implementation Research Network at PRC at UMass Chan

GLP - 1

At a glance

Phase: Phase not stated
Study type: Interventional
Sponsor: University of Massachusetts, Worcester
Enrolment target: 220
Started: 22 July 2026
Main results due: 30 April 2029
Study sites: 1
Registry updated: 24 September 2026

Can you take part?

Aged 18 years and over.
Open to any sex.
You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria

Inclusion Criteria:

1. Began using a GLP-1 within the past 6 months
2. Currently using GLP-1
3. Plans to continue GLP-1 use
4. GLP-1 prescribed by their physician (e.g., not online or 3rd party vendor)
5. BMI ≥27 kg/m2
6. Age 18 years of age and older
7. Speaks and reads English or Spanish
8. Willing to enroll in a digital lifestyle intervention for 4-months
9. Willing to wear a Fitbit for 8 months

Exclusion Criteria:

1. Was taking a GLP-1 within the 2 months prior to the current GLP-1 start date
2. Currently participating in a structured lifestyle change program (receiving structured guidance and counseling on physical activity, diet or weight loss)
3. Currently pregnant
4. Planning to become pregnant in the next year
5. Active diagnosis of an eating disorder
6. Active diagnosis of Schizophrenia or bipolar disorder
7. Unable to walk without assistance/assistive device or have restricted walking
8. Inability to understand the study and provide informed consent
9. Any physical, cognitive, or psychiatric condition that poses a risk or interferes with their ability to participate at the discretion of the study PI (Co-Is: in consultation with PI or if acting as/standing in for PI)

What this study is about

In the sponsor’s own words, from the registry.

The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.

Study sites(1)

UMass Chan Medical School - Shaw Building
Worcester, Massachusetts, United States
Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07481305. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me